原发性胰腺癌患者高强度聚焦超声治疗前后外周血CD4+CD25+
调节性T细胞的变化及其意义

吉林大学学报(医学版)

原发性胰腺癌患者高强度聚焦超声治疗前后外周血CD4+CD25+
调节性T细胞的变化及其意义

宋晓燕¹，马宁²，姜振宇²，张彦东²，杜冰洋¹

1. 吉林省吉林市中心医院肿瘤诊治中心二组,吉林吉林 132011；2. 吉林大学第一
医院风湿免疫科,吉林长春 130021

收稿日期:2013-01-24 出版日期:2013-07-28 发布日期:2013-08-17
通讯作者: 姜振宇（Tel:0431-88782060,E-mail:jlujzy@yhaoo.com.cn） E-mail:jlujzy@yhaoo.com.cn
作者简介:宋晓燕（1981-），女，吉林省磐石市人，主治医师，医学硕士，主要从事肿瘤疾病的基础与临床研究。
基金资助:
吉林省科技厅科研基金资助课题（20090454）


Changes of peripheral blood CD4+CD25+ regulatory T
cells in patients with primary pancreatic cancer before and after
treatment of high intensity focused ultrasound and significance

SONG Xiao-yan¹,MA Ning²,JIANG Zhen-yu²,ZHANG Yan-dong²,DU Bing-yang¹

1.Center of Tumor Diagnosis and Treatment,Center Hospital of Jilin City,Jilin
Province,Jilin 132011,China;2.Department of Rheumatology,First Hospital,Jilin University,Cha
ngchun 130021,China

Received:2013-01-24 Online:2013-07-28 Published:2013-08-17

摘要/Abstract

摘要：

目的：探讨原发性胰腺癌患者接受高强度聚焦超声(HIFU)治疗前后外周血CD4+
CD25+调节性T细胞的变化,阐明HIFU治疗对原发性胰腺癌患者免疫功能的影响。方
法：原发性胰腺癌组患者36例，对照组体检健康者28例，于HIFU治疗前、治疗4周后分别抽取外周静脉血，采
用流式细胞术检测外周血中CD4+CD25+调节性T细胞的百分比，并比较治疗前后原发性胰
腺癌患者KPS评分和癌胚抗原（CEA）、糖类抗原199（CA-199）水平的变化。结果： HIFU治疗前原发性胰腺癌组患者
外周血 CD4+ CD25+ 调节性T细胞百分比高于对照组,差异有统计学意义（P<0.01）；原发性胰腺癌组患者经HIFU治疗4周后外周血CD4+CD25+调节性T细胞百分比较治疗前明显下降,差异有统计学意义（P<0.01）。原发性胰腺癌组患者治疗后KPS评分与治疗前比较明显上升，差异有统计学意义（P<0.05）；CEA和CA-199水平与治疗前比较均明显下降，差异有统计学意义（P<0.05）。结论：HIFU治疗可以改善原发性胰腺癌患者的细胞免疫功能。

关键词: 高强度聚焦超声, 胰腺肿瘤, CD4+CD25+调节性T细胞

Abstract:

Objective To investigate the changes of peripheral blood CD4+CD25+
regulatory T cells in patients with primary pancreatic cancer before and after
treatment of high intensity focused ultrasound(HIFU),and to elucidate the effects of HIFU treatment on immune fun
ction of the patients with primary pancreatic cancer. Methods
Flow cytometry was used to detect the percentage
of CD4+CD25+ regulatory T cells in peripheral blood of the patients
in pancreatic carcinoma group(n=36) before and 4 weeks after HIFU treatment and healthy persons in control group(n=28).The KPS scores,the levels of CEA
and CA-199 of the patients with primary pancreatic cancer before and after treatment were compared.
Results The percentage of CD4+CD25+ regulatory T cells of the patients before HIFU treatment was significantly higher than that in control group,the difference was statistically significant (P<0.01).The percentage of CD4+CD25+ regulatory T cells of the patients in pancreatic cancer group 4 weeks after HIFU treatment was lower than before treatment,the difference was statistically significant (P<0.01).The KPS score of 36 patients with primary pancreatic cancer after HIFU treatment was significantly increased compared with before treatment,the difference was statistically significant ( P<0.05 ).The
levels of CEA and CA-199 of the patients after HIFU treatment was significantly decreased compared with before treatment,the difference was statistically significant (P<0.05).Conclusion HIFU treatment can improve the cell immune function of the patients with pancreatic cancer.


Key words: high intensity focused ultrasound, pancreatic neoplasms, CD4+CD25+ regulatory T cells

中图分类号:

R735.9

宋晓燕，马宁，姜振宇，张彦东，杜冰洋. 原发性胰腺癌患者高强度聚焦超声治疗前后外周血CD4+CD25+
调节性T细胞的变化及其意义[J]. 吉林大学学报(医学版), 2013, 39(4): 791-794.

SONG Xiao-yan,MA Ning,JIANG Zhen-yu,ZHANG Yan-dong,DU Bing-yang. Changes of peripheral blood CD4+CD25+ regulatory T
cells in patients with primary pancreatic cancer before and after
treatment of high intensity focused ultrasound and significance[J]. Journal of Jilin University Medicine Edition, 2013, 39(4): 791-794.

[1]	周中伟,杜伟,宁宇,于晶,郭峰有,杨学良. SMARCB1/INI1缺失型未分化胰腺癌1例报告及文献复习[J]. 吉林大学学报(医学版), 2026, 52(2): 523-529.
[2]	李雨欣,杨露,李凤金,齐玲. 蟛蜞菊内酯对人胰腺癌PANC-1细胞铜死亡的诱导作用[J]. 吉林大学学报(医学版), 2026, 52(1): 182-191.
[3]	卢梦云,韩语诚,胡溢洪,何旻蕙,张艳群,邹先琼. 糖脂转运蛋白对胰腺癌PANC-1细胞增殖、迁移和侵袭的影响及其机制[J]. 吉林大学学报(医学版), 2025, 51(2): 284-295.
[4]	杨露,傅家财,李凤金,齐玲. 五味子乙素对胰腺癌细胞迁移和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2025, 51(1): 44-50.
[5]	傅家财,秦玲莎,杨露,宋美慧,张仙映,刘晓翠,李凤金,齐玲. 五味子乙素对胰腺癌Pan02细胞增殖的抑制作用及其机制[J]. 吉林大学学报(医学版), 2024, 50(3): 638-646.
[6]	李锐,谭晓冬,胡耀元. 茯苓酸对人胰腺癌PANC-1细胞迁移、侵袭和上皮间质转化的抑制作用[J]. 吉林大学学报(医学版), 2023, 49(2): 315-323.
[7]	武晓慧,杨帆,郭新茹,袁轲,马综艺,廉婷,JHA Rajiv Kumar. 奥利司他联合EZH2抑制剂GSK126对胰腺癌细胞脂质代谢重编程的影响[J]. 吉林大学学报(医学版), 2023, 49(1): 55-66.
[8]	李承圣,包绮晗,郝晓燕,潘庆忠,王素珍,石福艳. 基于随机森林算法的胰腺癌术后预测模型构建[J]. 吉林大学学报(医学版), 2022, 48(2): 426-435.
[9]	陆路,黎东明,王学国,宋丹,王太成,赵红岩,吴晓勇. 氯喹通过影响胰腺癌细胞自噬和线粒体功能对吉西他滨耐药细胞的作用及其机制[J]. 吉林大学学报(医学版), 2021, 47(4): 926-933.
[10]	王云检, 张珉, 蒙博, 尤国华, 张璐阳. 雷公藤甲素对裸鼠胰腺癌皮下移植瘤生长的抑制作用及其机制[J]. 吉林大学学报(医学版), 2019, 45(02): 234-238.
[11]	王云检, 张珉, 蒙博, 尤国华. 大黄牡丹汤对胰腺癌大鼠的治疗作用和肝肾保护作用[J]. 吉林大学学报(医学版), 2017, 43(06): 1069-1073.
[12]	杜思韵, 盖保东, 屈佳, 杨冬艳. 经皮超声引导与开腹术中超声引导植入放射性¹²⁵I粒子治疗胰腺癌的效果比较[J]. 吉林大学学报(医学版), 2017, 43(02): 381-385.
[13]	孙小梅, 夏文明, 姜新, 陈祥, 李涛, 曲雅勤. 局部晚期胰腺癌容积旋转调强与五野调强放疗的剂量学比较[J]. 吉林大学学报(医学版), 2017, 43(02): 365-368.
[14]	张宁, 王颖娴, 胡健, 郑婕, 王晓琴. 血清CA199、C3、C4及脂类代谢水平在胰腺癌临床诊断中的应用[J]. 吉林大学学报(医学版), 2016, 42(02): 295-300.
[15]	李静，梁晓芳，翟桂兰. 血清CA199、CA125和CEA联合检测在胰腺癌诊断中的应用[J]. 吉林大学学报(医学版), 2014, 40(06): 1252-.